Red Light Holland Corp. (OTCQB:TRUFF) announced its financial results Friday for the three months ending Sept. 30, 2024, reporting revenue of CA$1.37 million ($998,263), up by 39.1% from CA$983,324 in the same period last year. For the six months ended Sept. 30, 2024, the company disclosed revenue of CA$2.93 million, up by 33.9%, from CA$2.19 million in the same period of 2023.

The Ontario-based company produces and sells functional mushrooms and mushroom home grow kits in North America and Europe, and a range of psilocybin truffles to the legal, recreational market in the Netherlands.

“Our Q2 results reflect our unwavering commitment to sustainable growth, strategic partnerships, and strong financial discipline," stated Todd Shapiro, CEO and director of Red Light Holland. "With revenues growing by 33.9% year-over-year and a significant reduction in EBITDA and adjusted EBITDA, we are clearly on the path to long-term profitability. Notably, nearly all our income-generating portfolio companies have seen growth, with every business over the last 12 months, except one (Mush Room & More), running in the black in terms of operating cash flow as a net positive company-excluding depreciation, corporate costs, and other non-operational expenses. This is a clear indication of how well we are managing our operations."

The company also announced that Ann Barnes has departed from the company’s board of directors and it will name a new board member in the coming weeks.

Read Also: Canadian Cannabis Co. Entourage Health Shares Spike On 8% YoY Q3 Revenue Growth, Reduced Losses

Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

Financial Highlights

• Gross profit for three and six months: CA$551,931 and CA$1.18 million compared to CA$444,668 and CA$967,765 in the same periods last year.
• Net loss for three and six months: CA$590,455 and CA$1.11 million compared to loss of CA$2.04 million and CA$2.99 million in the same periods last year.
• EBITDA loss for three and six months: CA$319,903 and CA$1.53 million compared to EBITDA loss of CA$897,100 and CA$2.57 million in the same periods last year.
• Adjusted EBITDA loss for three and six months: CA$480,720 and CA$715,189 compared to adjusted EBITDA loss of CA$1.05 million and CA$1.48 million in the same periods last year.

• Additional Cash: Received a sales tax refund and interest on Nov. 19,2024, of CA$868,960 and Costco payment on receivables of CA$468,668 on November 8, 2024, bringing the cash balance to approximately CA$13.5 million as of today
• Cash Balance: CA$12.79 million as of September 30, 2024, including restricted cash (CA$14.37 million as at March 31, 2024)
• Total Assets: CA$23.3 million (CA$24.1 million as at March 31, 2024)

Outlook

The company said it remains committed to its strategic path of profitability and continued advocacy for the legalization of, and adult access to psilocybin.

“Red Light Holland’s motto is: ‘Mind, Body, Gain – Grow your health, Build your wealth.’ We look forward to what the New Year can bring,” added Shapiro.

Price Action

Red Light Holland shares closed Friday's market session flat at $0.034 per share.

Read Next:

• Ayurcann Cannabis Co. Reports 28% YoY Net Revenue Growth In Q1 With Strong Performance In Vapes And Pre-Rolls

Photo: Courtesy of Bigc Studio via Shutterstock

Red White & Bloom Brands Inc. (CSE:RWB) reported its condensed interim consolidated financial statements Friday for its third quarter ended Sept. 30, 2024. Canadian cannabis company disclosed quarterly revenue of CA$21.7 million ($15.47 million) compared to CA$20.1 million in the same period last year.

“Our primary focus has been, and remains, optimizing the business through careful analysis of all legacy, non-core assets and operations, with the goal of transitioning RWB into a profitable enterprise," stated company president Colby De Zen. "Over the first nine months of the fiscal year, we have made significant strides toward achieving our strategic objectives. Our EBITDA has increased 20 times compared to the same period last year, reaching approximately $7.5 million. Adjusted EBITDA stands at $9.6 million for the same period. These improvements reflect all of the RWB team's efforts in achieving more profitable revenue streams through organizational efficiencies and exiting unprofitable product lines and ventures.”

Read Also: Cannabis-Focused RIV Capital Reports 186% YoY Surge In Q3 Revenue Ahead Of Major Merger That Will Cover 25% Of US Population

Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

Q3 Financial Highlights

• Gross profit before fair value adjustments was CA$7.0 million, down from CA$7.9 million, primarily due to inventory adjustments at Emblem Group.
• Gross profit after fair value adjustments rose to CA$10.3 million from CA$6.6 million.
• Adjusted EBITDA was CA$3.85 million compared to adjusted EBITDA of CA$4.82 million in the same period last year.
• Net loss narrowed to CA$1.84 million from CA$4.77 million in the same quarter of 2023.

Q3 Operational Milestones

• Red Light Holland's subsidiary Emblem Cannabis Corporation has been granted a total of 72 new Platinum and DIVVY product listings in preferred product formats across all provincial distributors, up from 67 as of 2024-Q2 close, including 35 listings approved by the Ontario Cannabis Store, up from 28 as of 2024-Q2 close.
• Added Prince Edward Island and New Brunswick to its Emblem distribution network with another Eastern province pending confirmation of activation in 2024-Q4 as well as continuing to increase penetration in existing markets such as Alberta, Saskatchewan, Manitoba, and British Columbia
• Updated genetics and refined cultivation processes at the Paris indoor facility, boosting efficiency, increasing THC potency, and improving harvest yields.
• Launched a new line of live rosin and live resin products in our California distribution network, further expanding our product portfolio.
• During the quarter, adult-use sales began in Ohio with Platinum Vape products under a licensing deal with a local producer.
• Continued with the corporate restructuring of our adult-use and medical-use retail operations in Michigan, contributing to prospective cost savings associated with variable and fixed overheads for each of the target retail locations.

Read Next:

• Greenway Greenhouse Cannabis Sees 52% YoY Growth In Q2 Revenue Amid Rising Losses And Cost Challenges

Photo: Courtesy of iQoncept via Shutterstock